Abstract:Doxorubicin (DOX) is one of the most commonly used anticancer drugs; however, its clinical application is greatly limited due to its toxicity and chemotherapy resistance. The delivery of DOX by liposomes (Lipos) can improve the blood circulation time in vivo and reduce toxic side effects, but the drug's accumulation in the tumor is often insufficient for effective treatment. In this study, we present a calcium cross-linked liposome gel for the encapsulation of DOX, demonstrating its superior long-term release capabilities compared to conventional Lipos. By leveraging this enhanced long-term release, we can enhance drug accumulation within tumors, ultimately leading to improved antitumor efficacy. Lipos were prepared using the thin-film dispersion method in this study. We utilized the ion-responsiveness of glutathione-gelatin (GSH-GG) to form the gel outside the Lipos and named the nanoparticles coated with GSH-GG on the outside of Lipos as Lipos@GSH-GG. The average size of Lipos@GSH-GG was around 342.9 nm, with a negative charge of -25.6 mV. The in vitro experiments revealed that Lipos@GSH-GG exhibited excellent biocompatibility and slower drug release compared to conventional Lipos. Further analysis of cellular uptake and cytotoxicity demonstrated that Lipos@GSH-GG loading DOX (DOX&Lipos@GSH-GG) exhibited superior long-term release effects and lower toxic side effects compared to Lipos loading DOX (DOX&Lipos). Additionally, the findings regarding the long-term release effect in vivo and the tumor accumulation within tumor-bearing mice of Lipos@GSH-GG suggested that, compared to Lipos, it demonstrated superior long-term release capabilities and achieved greater drug accumulation within tumors. In vivo antitumor efficacy experiments showed that DOX&Lipos@GSH-GG demonstrated superior antitumor efficacy to DOX&Lipos. Our study highlights Lipos@GSH-GG as a promising nanocarrier with the potential to enhance efficacy and safety by means of long-term release effects and may offer an alternative approach for effective antitumor therapy in the future.

Preparation and Characterization of TPGS-Modified Doxorubicin Liposomes

Synergistic Effects of Antitumor Efficacy Via Mixed Nano-Size Micelles of Multifunctional Bletilla Striata Polysaccharide-Based Copolymer and D-α-tocopheryl Polyethylene Glycol Succinate.

Preparation and Characterization of Cleavable PEG and TAT Peptide Co-modified Doxorubicin Liposomes

Preparation and in vitro studies of polysaccharide modified compound lipo-somes loaded with paclitaxel and doxorubicin

Preparation and in vitro characterization of octreotide-targeting doxorubicin liposome

In vitro characterization of two new doxorubicin liposomes modified with argine-glycine-aspartic acid tripeptide or glycine-argine-glycine-aspartic acid-serine pentapeptide

Preparation and Characterization of PEGylated Paclitaxel Liposomes

Hydrogelation of TPGS for Locoregional Combination Therapy of Cancer

Development and optimization of TPGS-based stealth liposome of doxorubicin using Box–Behnken design: characterization, hemocompatibility, and cytotoxicity evaluation in breast cancer cells

Preparation and in vitro Anti-tumor Effect of Glycyrrhetinic Acid-targeting Doxorubicin Liposome

34 A Ph-Sensitive Polymer Enhances the Specificity and Therapeutic Efficiency of Liposomal DOX in Vitro

Preparation and Characterization of Modified Lipid Nanoparticles for Doxorubicin Controlled Release.

Preparation and Quality Evaluation of Doxorubicin Hydrochloride Liposomes Optimized by High-pressure Microfluidics

Study of the preparation technology of Doxorubicin nanoliposomes

Preparation of Liposome Gel by Calcium Cross-Linking Induces the Long-Term Release of DOX to Improve the Antitumor Effect

Novel PLGGE Graft Polymeric Micelles for Doxorubicin Delivery

Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy

Formulation and Process Optimization of Doxorubicin-Loaded PLGA Nanoparticles and Its in Vitro Release

Preparation of Doxorubicin-Loaded Stealth Liposomes Modified with Transferrin and in Vitro Cell Research

Galactosylated Poly(ethylene Glycol)-B-poly(l-lactide-co-&szlig;-malic Acid) Block Copolymer Micelles for Targeted Drug Delivery: Preparation and in Vitro Characterization

In Vitro Evaluation of Polymeric Micelles Based on Hydrophobically-Modified Sulfated Chitosan As a Carrier of Doxorubicin